Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1Phase 2 1

Status

Unknown 1Terminated 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 4Gastrointestinal 3Other hematologic neoplasm 2Breast 2Tumor-Agnostic 1Thoracic 1Sarcoma 1Other 1Lymphoid 1Gynecologic 1Dermatologic 1

Conditions

Stomach Neoplasms 2Esophageal Squamous Cell Carcinoma 1Esophageal Neoplasms 1

Interventions

Oxaliplatin 1439Fluorouracil 1319Capecitabine 1114Gemcitabine 1057Leucovorin 939Bevacizumab 847Irinotecan 830Cisplatin 676Radiotherapy 560Cetuximab 482pembrolizumab 435Paclitaxel 401Drug Therapy 358Nivolumab 350130-nm albumin-bound paclitaxel 328Docetaxel 290Sorafenib 288S 1 (combination) 279Folfox protocol 266Albumin-Bound Paclitaxel 263Surgical Procedures, Operative 257lenvatinib 222sintilimab 218tislelizumab 214durvalumab 212regorafenib 209Magnetic Resonance Spectroscopy 205apatinib 204Radiosurgery 204Neoadjuvant Therapy 190

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Nutritional Support × Gastrointestinal × Clear all
NCT05714878 2024-05-10

Multimodal Prehabilitation for Resectable Gastric Cancer

Chinese PLA General Hospital

Phase NA Completed
70 enrolled
Gastrointestinal

Stomach Neoplasms

NCT01248299 2019-05-16

E-DIS

Centre Oscar Lambret

Phase 2 Terminated
105 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT02780921 2017-01-25

PREHAB

University Hospital, Clermont-Ferrand

Phase 3 Unknown
120 enrolled
Gastrointestinal

Esophageal Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡